A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC) / Recchia, F; Candeloro, G; Cesta, A; Desideri, Giovambattista; Necozione, Stefano; Rea, S.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 30:15(2012). [10.1200/jco.2012.30.15_suppl.e11041]
A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)
DESIDERI, GIOVAMBATTISTA
;
2012
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
